Prudential Financial’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-86,607
| Closed | -$970K | – | 2401 |
|
|
2017
Q3 | $970K | Sell |
86,607
-8,730
| -9% | -$96.3K | ﹤0.01% | 1846 |
|
|
2017
Q2 | $1.05M | Sell |
95,337
-600
| -0.6% | -$6K | ﹤0.01% | 1824 |
|
|
2017
Q1 | $940K | Sell |
95,937
-19,360
| -17% | -$193K | ﹤0.01% | 1873 |
|
|
2016
Q4 | $1.25M | Sell |
115,297
-35,640
| -24% | -$356K | ﹤0.01% | 1757 |
|
|
2016
Q3 | $1.55M | Sell |
150,937
-34,380
| -19% | -$374K | ﹤0.01% | 1632 |
|
|
2016
Q2 | $2.42M | Buy |
185,317
+111,300
| +150% | +$1.46M | ﹤0.01% | 1471 |
|
|
2016
Q1 | $815K | Sell |
74,017
-12,020
| -14% | -$107K | ﹤0.01% | 1877 |
|
|
2015
Q4 | $792K | Buy |
86,037
+13,800
| +19% | +$116K | ﹤0.01% | 1856 |
|
|
2015
Q3 | $501K | Buy |
72,237
+500
| +0.7% | +$4.28K | ﹤0.01% | 1942 |
|
|
2015
Q2 | $704K | Buy |
+71,737
| New | +$653K | ﹤0.01% | 1901 |
|
|
2014
Q3 | – | Sell |
-11,532
| Closed | -$61K | – | 2379 |
|
|
2014
Q2 | $61K | Sell |
11,532
-11,105
| -49% | -$54K | ﹤0.01% | 2374 |
|
|
2014
Q1 | $103K | Sell |
22,637
-21,500
| -49% | -$104K | ﹤0.01% | 2211 |
|
|
2013
Q4 | $222K | Sell |
44,137
-18,300
| -29% | -$88.1K | ﹤0.01% | 2161 |
|
|
2013
Q3 | $317K | Sell |
62,437
-200
| -0.3% | -$1.11K | ﹤0.01% | 2056 |
|
|
2013
Q2 | $311K | Buy |
+62,637
| New | +$298K | ﹤0.01% | 2053 |
|
Prudential Financial's SCLN Position: Q4 2017 in Review
Prudential Financial sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 86,607 shares — an estimated $970K sold.
Prudential Financial first reported a position in SCLN in Q2 2013 and held it in 15 quarters. The position peaked at $2.42M in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.
- Prudential Financial reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
- Prudential Financial sold 86,607 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $970K.
- Prudential Financial first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- Prudential Financial's Sciclone Pharmaceuticals Inc position peaked at $2.42M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.
Based on Prudential Financial's 13F filing for Q4 2017, filed 13 Feb 2018.